PARLIAMENTARY WRITTEN QUESTION
Vaccination (4 May 2020)
Question Asked
Asked by:
Matt Western (Labour)
Answer
The Vaccines Taskforce is working with the BioIndustry Association Taskforce to review and increase where possible, existing domestic capability to manufacture vaccines in response to COVID-19. This includes a review of the acceleration and increasing capacity of the Vaccines Manufacturing and Innovation Centre, so that it becomes operational earlier than planned and can manufacture population level doses.
For COVID-19, the type of vaccine manufacturing capacity needed will be determined by the nature of the vaccine that is developed and the technology used to produce the vaccines. The scale of facility needed will depend on how potent the vaccines are, and the productivity of the processes used to produce them. This work is proceeding at pace across different vaccine types, while those vaccines are still under development.
Answered by:
Jo Churchill (Conservative)
15 May 2020
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.